Apply Now for the Success of Your Breakthrough Innovation

Access to proven operators, entrepreneurs, and investors. 

This is your chance to turn your breakthrough innovation into a high-growth healthtech company with capital, expertise, and a powerful ecosystem behind you. Whether you’re still pre-incorporation or already building your startup, NLC will support your path to clinical and commercial impact.

NLC is the world’s leading healthtech venture builder. Our model is simple but powerful: based on our deep market insight, we find the world’s most exciting breakthrough innovations emerging from top institutions, build ventures around them, and scale these rapidly, accelerating their journey from lab to bedside.

The Opportunity for You:

  • Investment: Up to €500K per selected venture to fast-track your development.
  • Hands-on support from 40+ specialists, dedicated business units, and a track record of scaling 100+ healthtech ventures.
  • Ecosystem Access: Tap into our network of industry leaders, investors, and partners to accelerate development and adoption.
  • Proven Model: We combine entrepreneurship, operations, and investment to build and grow companies that make a real difference in patients’ lives.

 

Who Should Apply

We’re looking for bold inventors or early stage startups

  • Stage: Pre-incorporation or incorporated companies without professional VC investors.
  • Location: Willingness to incorporate or move to the Netherlands, with Dutch employees or partnerships (manufacturing, CROs, clinical collaborations).
  • Development:
    • Medtech: Functional prototype with preclinical data.
    • Biotech: In vivo proof of concept in relevant disease model

Focus Areas

We welcome applications across healthtech, with particular interest in:

  • Cardiovascular 
  • Image-guided therapy, sensing & navigation
  • Orthopaedics & Spine
  • Surgery and Neurotech
  • Therapeutics (metabolic disorders, neurology, I&I, oncology)

If your innovation doesn’t fit neatly into these categories but has strong patient impact potential — we still want to hear from you.

Deadline: December 15, 2025Only four ventures will be selected

SUBMIT YOUR INNOVATION HERE